A Blind, Randomized and Controlled Clinical Trial to Evaluate the Safety of Live Attenuated Varicella Vaccines for Healthy Adults, Adolescents and Children
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2017
Price : $35 *
At a glance
- Drugs Varicella zoster vaccine Sinovac Biotech (Primary)
- Indications Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors Sinovac Biotech
- 19 Oct 2016 According to a Sinovac Biotech media release, status changed from active, no longer recruiting to completed.
- 26 May 2016 Status changed from not yet recruiting to recruiting, as reported in a Sinovac Biotech media release.
- 05 Apr 2016 According to a Sinovac Biotech media release, the clinical trials of varicella vaccine are expected to be launched in the first half of 2016.